Fig. 2: Prognostic association of imaging response as per MY-RADS.
From: Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma
A Kaplan–Meier curve contrasting the groups with no detectable disease (RAD1) vs patients with detectable disease (RAC2+) on WB-MRI as per MY-RADS criteria at day 100 post-ASCT. A for PFS B for OS.
